ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

SCR Simcere Pharmaceutical Grp. Simcere Pharmaceutical Grp. American Depositary Shares

9.60
0.00 (0.00%)
14 Jun 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
Simcere Pharmaceutical Grp. Simcere Pharmaceutical Grp. American Depositary Shares NYSE:SCR NYSE Ordinary Share
  Price Change % Change Share Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 9.60 0.00 01:00:00

Simcere Pharmaceutical Group Announces Appointment of Chief Scientific Officer

15/10/2013 11:34am

PR Newswire (US)


Simcere Pharmaceutical Grp. Simcere Pharmaceutical Grp. American Depositary Shares (NYSE:SCR)
Historical Stock Chart


From Jun 2019 to Jun 2024

Click Here for more Simcere Pharmaceutical Grp. Simcere Pharmaceutical Grp. American Depositary Shares Charts.

NANJING, China, Oct. 15, 2013 /PRNewswire/ -- Simcere Pharmaceutical Group ("Simcere" or the "Company") (NYSE: SCR), a leading pharmaceutical company specializing in the development, manufacturing, and marketing of branded and proprietary pharmaceuticals in China, today announced the appointment of Dr. Zang Jingwu as Chief Scientific Officer of the Company, effective October 8, 2013.

Dr. Zang received his medical degree from Shanghai JiaoTong University School of Medicine. He earned a PhD from the University of Brussels and was a post-doctoral fellow at Harvard Medical School. Dr. Zang later joined the faculty of Baylor College of Medicine as a professor of Neurology and holds a medical license in the State of Texas in US. In his career in China, Dr. Zang was the founding director of the Institute of Health Sciences and Institute Pasteur Shanghai of the Chinese Academy of Sciences. In 2007, Dr. Zang joined GSK as Senior VP and head of GSK's R&D Centre in China; and in 2012, he held one more position as the global head of Neurosciences Therapy Area in GSK.

Mr. Hongquan Liu, the Chief Executive Officer of Simcere, said, "We are extremely pleased that Jingwu will be joining the Simcere management team to lead our R&D efforts. With his rich industry experience and solid knowledge of new drug development, we are confident that Jingwu will be an important contributor to Simcere as we continue to broaden our pipeline of innovative medicines."

About Simcere Pharmaceutical Group

Simcere Pharmaceutical Group ("Simcere" or the "Company") (NYSE: SCR) is a leading pharmaceutical company specializing in the development, manufacturing, and marketing of branded and proprietary pharmaceuticals in China. Simcere concentrates its research and development efforts on the treatment of diseases with high incidence and/or mortality rates and for which there is a clear demand for more effective pharmacotherapy such as cancer, strokes, cardiovascular disease, infectious diseases and pain. For more information about Simcere Pharmaceutical Group, please visit www.simcere.com.

Investor and Media Contacts:

Email: ir@simcere.com

In Nanjing:

Vivien Liang

Simcere Pharmaceutical Group

Tel: 86-25-8556-6666*8857

In the United States:

Cindy Zheng

Brunswick Group LLC

Tel: 1-212-333-3810



In Beijing:

Yue Yu

Brunswick Group

Tel: 86-10-5960-8600


SOURCE Simcere Pharmaceutical Group

Copyright 2013 PR Newswire

1 Year Simcere Pharmaceutical Grp. Simcere Pharmaceutical Grp. American Depositary Shares Chart

1 Year Simcere Pharmaceutical Grp. Simcere Pharmaceutical Grp. American Depositary Shares Chart

1 Month Simcere Pharmaceutical Grp. Simcere Pharmaceutical Grp. American Depositary Shares Chart

1 Month Simcere Pharmaceutical Grp. Simcere Pharmaceutical Grp. American Depositary Shares Chart

Your Recent History

Delayed Upgrade Clock